Back to Search
Start Over
Genomics in acute myeloid leukemia: from identification to personalization.
- Source :
-
Rhode Island Medical Journal . Nov2015, Vol. 98 Issue 11, p27-30. 4p. - Publication Year :
- 2015
-
Abstract
- Acute Myeloid Leukemia (AML) is an aggressive bone marrow malignancy that is fatal if left untreated. Previous classification was strictly based on morphology, which gave little information in terms of prognosis or guide to treatment. Recent research has provided vital information into the chromosomal and molecular pathogenesis of leukemia development. The discovery of these abnormalities via proteomics and genomics have provided two key insights. First, these novel discoveries provide prognostic significance into the predictive result of chemotherapy. Second, these chromosomal and protein abnormalities have provided potential drug targets for new treatment modalities. This article will elaborate on many of these new molecular findings and discuss their implications on the treatment of AML. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 03637913
- Volume :
- 98
- Issue :
- 11
- Database :
- Academic Search Index
- Journal :
- Rhode Island Medical Journal
- Publication Type :
- Academic Journal
- Accession number :
- 110645526